CVS Health reported $102.9 billion in revenues for the last quarter, a 7.8% increase year-over-year, and exceeded analysts' expectations by 4.1%. While the company has raised its total revenue guidance for 2025 to at least $400 billion and anticipates significant long-term earnings growth, its stock has fallen by 2.8% post-report. Notable price target adjustments by firms like JPMorgan and Bernstein reflect a complex outlook as CVS Health continues to play a leading role in the ACA Marketplace.
“Karen Lynch · earnings per year · average U.S. salary · $23,431,466”
“Leading players in the ACA Marketplace · include · managed care organizations UnitedHealth, CVS Health, Centene, Cigna, Elevance Health and Oscar Health”
“CVS Health · reported revenues of · 102.9 billion · up 7.8% year on year”
“CVS Health · outperformed analysts’ expectations by · 4.1%”
“CVS Health · reported revenues of · $102.9 billion · up 7.8% year on year”
“CVS Health · outperformed analysts’ expectations by · 4.1%”
“Leading players in the ACA Marketplace · include · managed care organizations UnitedHealth, CVS Health, Centene, Cigna, Elevance Health and Oscar Health”
“CVS Health · has been on · Zacks.com's list of the most searched stocks”
“CVS Health · has returned · +2.9% · over the past month”
“CVS Health · is expected to post earnings of · $0.99 per share · for the current quarter”
“CVS Health · represents a year-over-year change of · -16.8%”
“Zacks Rank · is rated · #3 (Hold) · for CVS Health”
